Skip to main content
Fig. 2 | EJNMMI Research

Fig. 2

From: Pretargeting of internalizing trastuzumab and cetuximab with a 18F-tetrazine tracer in xenograft models

Fig. 2

Maximum intensity projections (MIP) for representative mice administered with 11.4 MBq of [89Zr]Zr-DFO-cetuximab (a) and 7.3 MBq of [89Zr]Zr-DFO-trastuzumab (b) at different time points after injection in A431(a) and BT-474 (b) tumour-bearing mice (n = 3), respectively. The maximum intensity projections (MIPs) are scaled to the same percentages (100%) for intensity minimum and maximum to appropriately compare the images

Back to article page